drug · small molecule
38657
Phase 2updated 5mo agoby Novaliq GmbH🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 18 investigational indications.
targets
Peptidyl-prolyl cis-trans isomerase FKBP1A
all catalysts(0)
nothing on the calendar yet
Trials studying 38657
- phase3Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
- phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
- phase3Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
- phase2High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- phase3A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
- phase2Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- phase3A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
- phase2Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that